Caio Suartz

Assist Professor: @thenosm / Uro Oncologist: @TBRHSF Former Clin Fellow @LavalUniversity Former Res.fellow: UniversitéParis

[Uromigos @Uromigos]

🇧🇷 Five World Cup titles. Now, A Seleção wants another trophy! ⚽🏆

Team Brazil is bringing Jogo Bonito to the Uromigos World Cup, highlighting advances in penile cancer treatment, including new immunotherapy research.

They've made their case. Now they want your vote! 👀

#UromigosLive

[Tom Powles @tompowles1]

The 🇧🇷 Brazilian 🇧🇷 folks have been leading the way in penile cancer research, with the HERCULES trial showing ICI activity (with chemo) in advanced disease @OncoAlert

Brazil have won the football World Cup football ⚽️ 🏆 more than any other country. Can they be the 1st winner of #uromigosLive

[Caio Suartz @CSuartz]

@DVAraujoMD @JAMAOnc Excellent point, Daniel! This is particularly relevant in bladder cancer, where the annual cost of managing HRNMIBC can reach $29,000 with BCG and cystoscopic surveillance. With the immunotherapy and novel treatments, addressing financial toxicity must become a priority. Kudos!

[Daniel V. Araujo @DVAraujoMD]

Just out in @JAMAOnc... a summary of my view on how we can do more for financially constrained health systems using dose optimization principles and common sense.

Invite folks to read and discuss, curious where you agree and where you’d push back 👇

https://t.co/3pd73dTjk6

[Caio Suartz @CSuartz]

@TomRipley22 @SecRubio @emd_worldwide

[NEJM @NEJM]

Presented at #ESMO26:

In patients with muscle-invasive bladder cancer, event-free survival at 24 months was 63.5% with perioperative durvalumab plus neoadjuvant enfortumab vedotin as compared with 45.1% with surgery alone. Full phase 3 VOLGA trial results: https://t.co/9Eyzy0GnQq

@myESMO

[Caio Suartz @CSuartz]

The International Bladder Cancer Network has been active since 1997. It is an honor to be part and to attend presentations of research truly at the frontier of the field,lectures from some of the leading experts in BaC. A lot of learning and inspiration @IBCN1997

[Caio Suartz @CSuartz]

@IBCN1997 Excellent talk on the treatment of metastatic urothelial cancer. EV+P has brought a new treatment paradigm, but with it come new challenges, particularly regarding what to do after EV+P failure. Patient selection remains key, and we still need more studies.@DiMariaJiang

[Caio Suartz @CSuartz]

@NewsLiberdade Gilmar é de quinta categoria .

[Caio Suartz @CSuartz]

presentations. Grateful to the organizers and our team! @sbuoficial

[Caio Suartz @CSuartz]

Honored to speak at one of the world’s largest urology congresses, 3,000+ urologists, on NeuroSAFE robotic radical prostatectomy and new technologies in cystoscopy for bladder cancer diagnosis.
Even more special: our bladder cancer study won 2nd place overall among podium.

[Shilpa Gupta, MD, FASCO @shilpaonc]

Great discussions at @IBCG_BladderCA #IBCG26 tackling some of the most controversial topics affecting our decision-making at the point of care.

Bringing together global experts to debate the evidence, challenge current thinking, and build consensus where the data don’t always give us a clear answer.
@AndreaNecchi @mouwlab @LAUrology_NL @UroDocAsh @montypal @FaltasLab @siadaneshmand

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Very pleased to announce Mario Fernandez as the inaugural LATAM Liaison on the IBCG Board.

Mario will help us broaden IBCG’s engagement across Latin America, strengthen regional relationships, and create new opportunities for collaboration, education, and scientific exchange.

Could not think of a better person to help lead this effort.
@UrogerliMD @pjhensley11 @AmirHorowitz @mouwlab @spsutkaMD @shilpaonc @AndreaNecchi @LAUrology_NL @karima_oualla @joanfundi @PGrivasMDPhD @marigfern @SpiessPhilippe @IBCG_BladderCA #IBCG26

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Delighted to welcome Phil Spiess to the IBCG Board as our inaugural GSRGT Liaison.

This new role will help deepen collaboration between IBCG and the Global Society of Rare Genitourinary Tumors, with a focus on areas of shared scientific and strategic interest.

Looking forward to what we can build together. @GTumors @UrogerliMD @pjhensley11 @AmirHorowitz @mouwlab @spsutkaMD @shilpaonc @AndreaNecchi @LAUrology_NL @karima_oualla @PGrivasMDPhD @marigfern @SpiessPhilippe @IBCG_BladderCA #IBCG26

[Caio Suartz @CSuartz]

@EurUrolOncol @EUplatinum

-HIFI-2
- HEAT & ICE — 10-year outcomes

Where does the evidence stand today? Who are the right patients? And where should we draw the line?

https://t.co/lYx4a7RWtf

[Caio Suartz @CSuartz]

Uro Oncology - Beyond the Abstract -
This week: focal therapy for prostate cancer.

A timely topic following the recent CFM approval in Brazil and two Research Matters pieces highlighting the rapid growth of focal therapy in the US.
We discuss two important papers from:

[Caio Suartz @CSuartz]

Truly honored and grateful for the invitation to speak on adjuvant immunotherapy in bladder cancer, alongside such distinguished leaders in uro-oncology. A great opportunity to exchange perspectives, discuss the evolving evidence, and contribute to a high-level scientific disc.

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

20 years ago, IBCG started with a small group around a table.

Later this month, friends and colleagues from around the world gather in Houston for #IBCG26. Two days around the table tackling some of the hardest questions in #BladderCancer, debating the evidence and challenging each other on where we go next.

Looking forward to seeing you all!

@UrogerliMD @spsutkaMD @LAUrology_NL @shilpaonc @mouwlab @pjhensley11 @AndreaNecchi @AmirHorowitz @PGrivasMDPhD @karima_oualla @SimaPorten @joanfundi @marigfern

[Caio Suartz @CSuartz]

@fcwinterfell15 @drsamiurologist You can pass a 26 Fr nephroscope and remove it with a three-prong grasper; otherwise, you can morcellate it.

[Sia Daneshmand, M.D. @siadaneshmand]

New in @JAMANetworkOpen: @SWOG S1600, a multicenter phase 3 RCT, found no reduction in 30- or 90-day complications w/ specialized immunonutrition vs standard nutrition after cystectomy. Exploratory DFS/OS favored immunonutrition. #BladderCancer
@JhamiltonReeves @DrJoeUnger @JMHolzbeierlein @FoxChaseCancer @BCM_Urology @JanetKukreja @eugenekanglee @URMCUrology @DrDawnHershman @fischmd @lynnhenrymd https://t.co/671sdA0D1y